# REGULATORY_REVIEW_SIMULATIONS.md

## 1. Purpose

This document defines simulated regulatory review scenarios for the MedIntel repository. Its purpose is to proactively stress-test MedIntel’s AI, data, and governance controls against foreseeable regulatory scrutiny. The simulations are designed to support medical AI compliance readiness, audit preparedness, and continuous regulatory alignment.

## 2. Scope

Applies to all MedIntel components, including:

* AI/ML models used for clinical or decision-support purposes
* Data ingestion, labeling, preprocessing, and inference pipelines
* Human-in-the-loop decision workflows
* Model monitoring, updates, and post-market surveillance

## 3. Regulatory Reference Landscape

Simulations are aligned against, but not limited to:

* Medical device software regulations (SaMD)
* Data protection and privacy frameworks (e.g., LGPD, GDPR, HIPAA-equivalent principles)
* AI governance and risk management standards
* Clinical decision support oversight requirements

## 4. Simulation Framework

Each simulation follows a standardized structure:

* Trigger Event
* Regulatory Question
* Evidence Requested
* MedIntel Response Artifacts
* Pass / Conditional / Fail Outcome
* Remediation Actions (if applicable)

## 5. Core Simulation Scenarios

### 5.1 Model Performance & Safety Review

**Trigger Event:** Regulator requests evidence that model performance is clinically acceptable.

**Regulatory Question:**
How does MedIntel demonstrate that AI outputs meet safety and effectiveness thresholds?

**Evidence Requested:**

* Primary performance metrics (e.g., F1-score, sensitivity, specificity)
* Validation datasets and evaluation methodology
* Model confidence thresholds

**Response Artifacts:**

* MODEL_PRIMARY_PERFORMANCE_METRIC.md
* AI_MODEL_CONFIDENCE_CALIBRATION.md
* AI_MODEL_SAFETY_CASE.md

**Outcome Criteria:**

* Clear metrics defined and justified
* Performance stability across datasets

---

### 5.2 Human Oversight & Clinical Independence

**Trigger Event:** Concern that AI recommendations override clinician judgment.

**Regulatory Question:**
What safeguards ensure AI does not replace human clinical decision-making?

**Evidence Requested:**

* Override mechanisms
* Disagreement and escalation logs
* Oversight enforcement policies

**Response Artifacts:**

* CLINICIAN_OVERRIDE_AND_DISAGREEMENT_LOG.md
* AI_HUMAN_OVERSIGHT_ENFORCEMENT_POLICY.md
* CLINICAL_DECISION_INDEPENDENCE.md

**Outcome Criteria:**

* Human authority is explicit and enforceable

---

### 5.3 Data Consent & Secondary Use

**Trigger Event:** Review of patient data reuse for model training.

**Regulatory Question:**
How is consent managed and secondary use restricted?

**Evidence Requested:**

* Consent records
* Data minimization controls
* Secondary-use approval logic

**Response Artifacts:**

* DATA_CONSENT_AND_SECONDARY_USE_POLICY.md
* DATA_MINIMIZATION_AND_PURPOSE_LIMITATION_POLICY.md
* DATA_PROVENANCE_AND_LINEAGE.md

**Outcome Criteria:**

* Consent traceability and enforceable limits

---

### 5.4 Model Change & Update Control

**Trigger Event:** Deployment of an updated AI model.

**Regulatory Question:**
How does MedIntel ensure changes do not introduce new risks?

**Evidence Requested:**

* Change impact assessment
* Versioning and rollback procedures
* Regression testing evidence

**Response Artifacts:**

* AI_MODEL_CHANGE_IMPACT_ASSESSMENT.md
* AI_MODEL_VERSIONING_AND_ROLLBACK_POLICY.md
* MODEL_DATA_QUALITY_ACCEPTANCE_CRITERIA.md

**Outcome Criteria:**

* Controlled, auditable update process

---

### 5.5 Post-Market Surveillance

**Trigger Event:** Ongoing regulatory monitoring request.

**Regulatory Question:**
How does MedIntel monitor real-world performance and safety after deployment?

**Evidence Requested:**

* Incident reports
* Drift detection metrics
* Escalation and response workflows

**Response Artifacts:**

* RPM_POST_MARKET_SURVEILLANCE_PLAN.md
* RPM_INCIDENT_RESPONSE_AND_RECOVERY_PROTOCOL.md
* POST_MARKET_MODEL_SURVEILLANCE_REPORTING.md

**Outcome Criteria:**

* Continuous monitoring and rapid response capability

---

## 6. Simulation Execution Cadence

* Mandatory execution before major releases
* Annual full regulatory simulation cycle
* Ad-hoc simulations triggered by incidents or regulator inquiries

## 7. Documentation & Record Retention

All simulation outputs, findings, and remediation actions must be:

* Logged immutably
* Retained per GOVERNANCE_RECORD_RETENTION_POLICY.md
* Made available to authorized auditors upon request

## 8. Accountability

Ultimate accountability for regulatory readiness resides with:

* MedIntel Governance Committee
* Designated Clinical Safety Officer
* Data Protection & AI Compliance Leads

---

**Status:** Mandatory
**Repository:** MedIntel
**Audience:** Regulators, Auditors, Internal Compliance Teams

